Novartis AG (NVS)
Health Care
Novartis AG (NVS) is listed on the New York Stock Exchange, where its shares have traded since November 7, 1996. SentiSense covers Novartis AG in the Health Care sector. Vasant Narasimhan is its chief executive officer. The company reports 75,267 employees, and its corporate website is www.novartis.com.
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Latest reported results
Novartis AG reported revenue of $15.03 billion for Q3 FY2026, up 4.7% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1,598 institutions reported holding NVS, with 135.0 million shares worth $21.1 billion in aggregate. The largest reported holders were Fisher Asset Management, Morgan Stanley and Dimensional Fund Advisors. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on NVS
- NVS sentiment: whether news and social coverage of Novartis AG leans bullish or bearish, and the stories driving it.
- NVS ownership: all 1,598 reporting institutions, plus insider and congressional trades.
- NVS financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Novartis AG: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Novartis AG do?
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic.
What sector is NVS in?
SentiSense classifies Novartis AG in the Health Care sector.
Where does NVS stock trade?
Novartis AG (NVS) is listed on the New York Stock Exchange, where its shares have traded since November 7, 1996.
Who is the CEO of Novartis AG?
Vasant Narasimhan is the chief executive officer of Novartis AG.